December 12, 2016
Date: Dec 12, 2016
Duration: 20 Min
Sponsored by Thermo Fisher Scientific
This webcast features: Orjana Terova, Purification Product Manager, Thermo Fisher Scientific
There is a need in the industry for a standard purification strategy for the manufacture of novel molecules including viral vectors and oligomeric therapies. Working with customers, Thermo Fisher Scientific has developed innovative purification resins through the POROS™ custom resin program and CaptureSelect™ ligand technology. This combination of ligand and resin development has allowed for development of platform purification processes that increase productivity and improve product yield for gene therapies.
In this webcast:
Learn how the POROS™ CaptureSelect™AAV8 and AAV9 affinity resins capture and purify AAV8 and AAV9 viral vectors
Learn how using these affinity resins improves the efficiency of downstream processing
Learn how using the resins maximizes productivity and scalability with consistent process results
You May Also Like
